Publication: UVEITIS DUE TO IMMUNE-MEDIATED INFLAMMATORY DISEASES TREATED WITH CERTOLIZUMAB PEGOL. MULTICENTER STUDY OF 80 PATIENTS.
No Thumbnail Available
Identifiers
Date
2022-06-01
Authors
Martin-Varillas, J. L.
Sanchez-Bilbao, L.
Calvo-Rio, V.
Adan, A.
Hernanz Rodriguez, I.
Beltran, E.
Castro, S.
Fanlo Mateo, P.
Garcia Martos, A.
Torre-Salaberri, I.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Bmj publishing group
Metrics
Export
Abstract
Description
MeSH Terms
DeCS Terms
CIE Terms
Keywords
Adalimumab